InnerCool buy to bring cash to Cardium's coffers and strengthen heart portfolio
This article was originally published in Clinica
Executive Summary
InnerCool Therapies, the San Diego, California-based hypothermia systems developer, has agreed to sell substantially all its assets to interventional cardiology company Cardium Therapeutics.